Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biochim Biophys Acta Mol Basis Dis ; 1864(2): 488-498, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29158183

RESUMEN

Serine deficiency has been observed in patients with nonalcoholic fatty liver disease (NAFLD). Whether serine supplementation has any beneficial effects on the prevention of NAFLD remains unknown. The present study was conducted to investigate the effects of serine supplementation on hepatic oxidative stress and steatosis and its related mechanisms. Forty male C57BL/6J mice (9week-old) were randomly assigned into four groups (n=10) and fed: i) a low-fat diet; ii) a low-fat diet supplemented with 1% (wt:vol) serine; iii) a high-fat (HF) diet; and iv) a HF diet supplemented with 1% serine, respectively. Palmitic acid (PA)-treated primary hepatocytes separated from adult mice were also used to study the effects of serine on oxidative stress. The results showed that serine supplementation increased glucose tolerance and insulin sensitivity, and protected mice from hepatic lipid accumulation, but did not significantly decreased HF diet-induced weight gain. In addition, serine supplementation protected glutathione (GSH) antioxidant system and prevented hypermethylation in the promoters of glutathione synthesis-related genes, while decreasing reactive oxygen species (ROS) in mice fed a HF diet. Moreover, we found that serine supplementation increased phosphorylation and S-glutathionylation of AMP-activated protein kinase α subunit (AMPKα), and decreased ROS, malondialdehyde and triglyceride contents in PA-treated primary hepatocytes. However, while AMPK activity or GSH synthesis was inhibited, the abovementioned effects of serine on PA-treated primary hepatocytes were not observed. Our results suggest that serine supplementation could prevent HF diet-induced oxidative stress and steatosis by epigenetically modulating the expression of glutathione synthesis-related genes and through AMPK activation.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Epigénesis Genética , Glutatión/metabolismo , Hepatocitos/metabolismo , Serina/química , Animales , Antioxidantes/metabolismo , Metilación de ADN , Dieta Alta en Grasa/efectos adversos , Grasas de la Dieta/metabolismo , Suplementos Dietéticos , Prueba de Tolerancia a la Glucosa , Hepatocitos/citología , Insulina/metabolismo , Lípidos/sangre , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Estrés Oxidativo , Especies Reactivas de Oxígeno/metabolismo , Triglicéridos/metabolismo
2.
J. physiol. biochem ; 71(4): 753-762, dic. 2015.
Artículo en Inglés | IBECS | ID: ibc-145727

RESUMEN

Resveratrol improves mitochondrial function, and recent evidences demonstrate that miRNAs play important roles in certain effects of resveratrol. In the current study, we found that a microRNA, miR-27b, was significantly induced in a dose-dependent way in skeletal muscle and C2C12 myoblast treated with resveratrol. Our results showed that overexpression of miR-27b could mimic the effects of resveratrol on improving mitochondrial function and glucose uptake in skeletal muscle cells. Subsequently, we found that FOXO1 was a potential target of miR-27b, and the effects of resveratrol on mitochondrial function were significantly affected after inhibition of miR-27b. Moreover, the effects of miR-27b on mitochondrial function were lost after inhibition of Sirt1, although miR-27b and FOXO1 expression were not influenced. Taken together, these data suggested that overexpression of miR-27b could benefit mitochondrial function, while the effects of overexpressed miR-27b were Sirt1-dependent


Asunto(s)
Humanos , Fitoterapia/métodos , Antioxidantes/farmacocinética , Mitocondrias , Sirtuina 1/análisis , ARN Mensajero/genética , Sustancias Protectoras/farmacocinética
3.
J Physiol Biochem ; 71(4): 753-62, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26452502

RESUMEN

Resveratrol improves mitochondrial function, and recent evidences demonstrate that miRNAs play important roles in certain effects of resveratrol. In the current study, we found that a microRNA, miR-27b, was significantly induced in a dose-dependent way in skeletal muscle and C2C12 myoblast treated with resveratrol. Our results showed that overexpression of miR-27b could mimic the effects of resveratrol on improving mitochondrial function and glucose uptake in skeletal muscle cells. Subsequently, we found that FOXO1 was a potential target of miR-27b, and the effects of resveratrol on mitochondrial function were significantly affected after inhibition of miR-27b. Moreover, the effects of miR-27b on mitochondrial function were lost after inhibition of Sirt1, although miR-27b and FOXO1 expression were not influenced. Taken together, these data suggested that overexpression of miR-27b could benefit mitochondrial function, while the effects of overexpressed miR-27b were Sirt1-dependent.


Asunto(s)
MicroARNs/metabolismo , Mitocondrias Musculares/enzimología , Músculo Esquelético/enzimología , Sirtuina 1/fisiología , Animales , Antioxidantes/farmacología , Glucemia , Línea Celular , Evaluación Preclínica de Medicamentos , Proteína Forkhead Box O1 , Factores de Transcripción Forkhead/genética , Factores de Transcripción Forkhead/metabolismo , Expresión Génica , Masculino , Ratones Endogámicos C57BL , MicroARNs/genética , Interferencia de ARN , Resveratrol , Estilbenos/farmacología , Aumento de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA